| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/15/2022 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 400k | $1.44 | $576k | | 08/15/2022 |
| 06/10/2021 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 42.2k | $5.97 | $252.1k | | 06/10/2021 |
| 12/15/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 286k | $2.97 | $849.4k | | 12/15/2020 |
| 06/04/2020 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 40.1k | $6.48 | $260.1k | | 06/04/2020 |
| 03/17/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Purchase | Common Stock | 5k | $4.00 | $20k | By Trust | 03/17/2020 |
| 02/03/2020 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 1.3M | $1.36 | $1.7M | | 02/03/2020 |
| 09/10/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Purchase | Common Stock | 40k | $1.25 | $50k | | 09/10/2019 |
| 08/21/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Purchase | Common Stock | 20k | $0.99 | $19.8k | | 08/21/2019 |
| 06/11/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 300k | $1.87 | $561k | | 06/11/2019 |
| 06/06/2019 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 28.9k | $14.66 | $423.4k | | 06/06/2019 |
| 02/01/2019 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 300k | $3.35 | $1M | | 02/01/2019 |
| 10/11/2018 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 25.8k | $27.92 | $721.7k | | 10/11/2018 |
| 07/02/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Stock Option (right to buy) | 225k | $7.72 | $1.7M | | 07/02/2018 |
| 01/02/2018 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 225k | $9.23 | $2.1M | | 01/02/2018 |
| 01/30/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 500k | $11.87 | $5.9M | | 01/30/2017 |